Pavan Posted Fri 18th of February, 2011 19:58:26 PM
Will Medicare Part B pay for Infusion treatment of VPRIV for gauchir disease even if the treatment is before 14 day cycle in between two treatments.
SuperCoder Answered Sun 20th of February, 2011 15:57:35 PM
Effective for dates of service on or after January 1, 2011, providers must use HCPCS code J3385 (injection, velaglucerase alfa, 100 units), instead of HCPCS code J3590 (unclassified biologicals) to bill for velaglucerase alfa. Velaglucerase alfa is indicated for use in patients 4 years of age or older with a rare genetic disorder called Type I Gaucher disease. A Treatment Authorization Request (TAR) is required that must include a diagnosis of Type I Gaucher disease. The recommended dosage is 60 units/kg every other week as a 60-minute infusion.